Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
PaperCitations, authors & open-access status
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 302 citations, 2015 year and closed oa status.
302
Citations
2015
Year
closed
OA Status